retail news in context, analysis with attitude

USA Today reports that Johnson & Johnson is expanding its recall of Tylenol, Motrin and other over-the-counter drugs said to have a musty, moldy smell.

According to the story, “The company has already made a large recall of those drugs and over-the-counter products, saying about 70 people noticed the smell. Some of them got sick, with symptoms including nausea, stomach pain, vomiting and diarrhea. The odor was linked to a chemical in shipping pallets and traced to a facility in Puerto Rico. The company had planned to stop shipping those products on wooden pallets treated with the chemical, and asked its suppliers to do the same.”

The continuing recalls by J&J - which seem to be linked to a lack of internal quality control, and have caused sales of the company’s pain reliever pills to drop by 56 percent in the four weeks ending June 13 compared to the same period a year earlier, according to SymphonyIRI Group - are seen to have severely damaged the credibility of a company that set the standard for recalls with its Tylenol recall in the early eighties.
KC's View:
Maybe shareholders should get top management from J&J together with top management from Toyota, and ship them off to Devil’s Island or something. Because sometimes it feels like these folks have no clue.

Important lesson, I think. It was not that long ago that both companies were perceived as being examples of extraordinary leadership. Recent events show that “legendary” is a word used to describe the past. You have to re-earn that description every day. No excuses. No exceptions.